Thu, December 8, 2022
Wed, December 7, 2022
Tue, December 6, 2022

Geulah Livshits Maintained (ACHL) at Strong Buy with Decreased Target to $17 on, Dec 7th, 2022

Geulah Livshits of Chardan Capital, Maintained "Achilles Therapeutics plc" (ACHL) at Strong Buy with Decreased Target from $20 to $17 on, Dec 7th, 2022.

Geulah, nor any peers, have made any analyst calls on ACHL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30